Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Opioids Stories

118986294
2012-06-02 07:26:57

Scientists studying opium poppies say that they have pinpointed the genes responsible for producing a compound which can be used as a cough suppressant and cancer-fighting agent. According to Reuters reporter Ben Hirschler, researchers at the University of York and GlaxoSmithKline (GSK) located a cluster of 10 genes which they claim are responsible for the creation of noscapine within the poppies. Noscapine has been used for many years to fight coughs, and recent studies have shown that...

2012-05-31 23:03:22

Increased emphasis on arrests of drug dealers, especially those who provided drugs that resulted in overdose, helps make communities safer but can never be a complete solution. McAlester, Oklahoma (PRWEB) May 30, 2012 As heroin deaths increase across America, law enforcement and civic groups push for more arrests to deal with the problem. In many cities, when an overdose death occurs, the person who supplied the drug is arrested for homicide. While this provides a certain degree of justice...

2012-05-31 13:17:51

Penn researcher calls for expansion of programs to identify potential drug abusers and protect pain patients Individual use of prescription opioids has increased four-fold since the mid-1990s, in part due to increased awareness of pain control for chronic conditions such as low back pain and fibromyalgia and a Joint Commission mandate that hospitals assess patients' pain as a "vital sign" along with their blood pressure and temperature. During the same timeframe, however, the number of...

2012-05-31 02:25:53

PISGAH FOREST, N.C., May 31, 2012 /PRNewswire/ -- Pisgah Laboratories, Inc. (www.pisgahlabs.com) received Notice of Allowance from the United States Patent and Trademark Office (www.uspto.gov) for its patent application entitled "Opioid Salts and Formulations Exhibiting Anti-Abuse and Anti-Dose Dumping Properties." Pisgah began pursuing a technology platform in 2006 that addresses the nation's drug abuse epidemic and this patent is the first in what is expected to be a large estate of allowed...

2012-05-31 02:25:09

RALEIGH, N.C., May 31, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Jefferies 2012 Global Healthcare Conference in New York City. The presentation is scheduled for Thursday, June 7 at 3:30 P.M. Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on the clinical development program and timeline for BEMA...

2012-05-28 23:03:24

Curran, a psychiatrist, is known for his outspoken advocacy for people with addiction.As a founding member of Physicians and Nurses Against Tobacco, Dr. Curran has worked to engage spiritual leaders in the fight against tobacco industry. (PRWEB) May 27, 2012 A United States Congressional candidate is taking on the Pfizer Corporation and its ED commercials as one of his campaign issues. "These commercials are embarrassing. In less than thirty seconds these ads violate innocence, decency, and...

2012-05-23 02:26:47

SYDNEY and BEDMINSTER, N.J., May 23, 2012 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S. Patent No. 8,182,837, which does not expire until 2023. This patent covers a method of treatment of pain comprising the administration of the oral Dual Opioid®( )compositions of MoxDuo IR (Immediate Release) for the treatment of acute pain as well as MoxDuo CR (Controlled Release) for the...

2012-05-21 02:24:49

RALEIGH, N.C., May 21, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced receipt of a pre-launch milestone payment of $2.5 million from Meda in conjunction with the first country registration and pricing approval for BREAKYL (tradename for ONSOLIS in the E.U). A last milestone payment related to the E.U. of $2.5 million is payable at the time of commercial launch, which is anticipated in late 2012. BREAKYL will be commercialized in the E.U. by Meda....

2012-05-19 23:01:29

A recent Centers for Disease Control and Prevention report reveals extraordinary loss of life due to prescription drug abuse in New Mexico and West Virginia. Canadian, OK (PRWEB) May 19, 2012 Recent figures from the Centers for Disease Control and Prevention (CDC) reveal the extraordinary loss of life to prescription drug overdoses is being suffered by families in some states. This report shows that New Mexico has the highest rate of overdose deaths and West Virginia has the second highest...

2012-05-18 06:24:58

STAMFORD, Conn., May 18, 2012 /PRNewswire/ -- Purdue Pharma L.P. will present an analysis of data from completed clinical trials for Butrans®( )(buprenorphine) Transdermal System CIII at the American Pain Society's (APS) 31st Annual Scientific Meeting. The analysis includes an evaluation of supplemental analgesic use and pain scores across the 7-day dosing interval. (Logo: http://photos.prnewswire.com/prnh/20100921/NY67262 ) The poster will be presented at the APS meeting in...